{"DataElement":{"publicId":"2542147","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Adverse Event Outcome Type","preferredDefinition":"the type of result or resolution for a reported adverse event in an AIDS (acquired immunodeficiency syndrome, resulting from the acquired deficiency of cellular immunity caused by the HIV/human immunodeficiency virus) trial, following a treatment or therapy change.","longName":"AIDS_AE_OUTCOME_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2542073","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Adverse Event Outcome","preferredDefinition":"information relating to the result or resolution for a reported adverse event in an AIDS (acquired immunodeficiency syndrome, resulting from the acquired deficiency of cellular immunity caused by the HIV/human immunodeficiency virus) trial, following a treatment or therapy change.","longName":"AIDS_AE_OUTCOME","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"3081925","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Adverse Event","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004:Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.","longName":"C2851:C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85C82E27-BCE5-B724-E040-BB89AD436170","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-04","modifiedBy":"ONEDATA","dateModified":"2010-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224045","version":"1","preferredName":"Outcome","preferredDefinition":"A phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F061C-D115-4EFF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"223965DB-F1E4-3D10-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-30","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2542146","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Adverse Event Outcome Type","preferredDefinition":"the type of result or resolution for a reported adverse event in an AIDS (acquired immunodeficiency syndrome, resulting from the acquired deficiency of cellular immunity caused by the HIV/human immunodeficiency virus) trial, following a treatment or therapy change.","longName":"AIDS_AE_OUTCOME_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Resolved","valueDescription":"ADVERSE EVENT IS RESOLVED","ValueMeaning":{"publicId":"2558196","version":"1","preferredName":"ADVERSE EVENT IS RESOLVED","longName":"2558196","preferredDefinition":"ADVERSE EVENT IS RESOLVED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B061-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2239C1F6-20D6-66ED-E044-0003BA3F9857","beginDate":"2006-11-14","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-14","modifiedBy":"ONEDATA","dateModified":"2006-11-14","deletedIndicator":"No"},{"value":"Resolved with sequelae","valueDescription":"ADVERSE EVENT IS RESOLVED WITH SEQUELAE","ValueMeaning":{"publicId":"2558197","version":"1","preferredName":"ADVERSE EVENT IS RESOLVED WITH SEQUELAE","longName":"2558197","preferredDefinition":"ADVERSE EVENT IS RESOLVED WITH SEQUELAE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B062-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2239C1F6-20E8-66ED-E044-0003BA3F9857","beginDate":"2006-11-14","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-14","modifiedBy":"ONEDATA","dateModified":"2006-11-14","deletedIndicator":"No"},{"value":"Unresolved, protocol ongoing","valueDescription":"Unresolved, protocol ongoing","ValueMeaning":{"publicId":"2580847","version":"1","preferredName":"Unresolved, protocol ongoing","longName":"2580847","preferredDefinition":"Unresolved, protocol ongoing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-08DC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-09-13","modifiedBy":"ALAIS","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2239C1F6-20F4-66ED-E044-0003BA3F9857","beginDate":"2006-11-14","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-14","modifiedBy":"ONEDATA","dateModified":"2006-11-14","deletedIndicator":"No"},{"value":"Unresolved at protocol completion","valueDescription":"Unresolved at protocol completion","ValueMeaning":{"publicId":"2580848","version":"1","preferredName":"Unresolved at protocol completion","longName":"2580848","preferredDefinition":"Unresolved at protocol completion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-08DD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-09-13","modifiedBy":"ALAIS","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2239C1F6-20FF-66ED-E044-0003BA3F9857","beginDate":"2006-11-14","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-14","modifiedBy":"ONEDATA","dateModified":"2006-11-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"223A187B-03CE-584E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-14","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-14","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Outcome of Adverse Event","type":"Preferred Question Text","description":"Outcome of Adverse Event","url":null,"context":"CTEP"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"223A187B-03E4-584E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-14","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-14","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}